Alchemy 43 is a technology company.
Alchemy 43 has raised $3.0M across 1 funding round.
Alchemy 43 has raised $3.0M in total across 1 funding round.
Alchemy 43 has raised $3.0M in total across 1 funding round.
Alchemy 43's investors include Accel, BoxGroup, FirstMark Capital, Forerunner Ventures, General Catalyst.
Alchemy 43 is a medical aesthetics and wellness brand specializing in subtle, personalized "microtreatments" like BOTOX, dermal fillers, chemical peels, micro-needling, PRP, laser treatments, and medical weight loss support.[1][2][4] Founded in 2014 and headquartered in Beverly Hills, California, it serves individuals seeking natural aesthetic enhancements and wellness solutions through licensed medical providers who tailor treatments to lifestyle and facial harmony, with locations now in California, New York, and Texas.[1][4][5] The company has raised $3.2M in Series A funding from investors including LeadEdge Capital, Forerunner Ventures, and BAM Ventures, and operates as an "aesthetics bar" emphasizing effortless, confidence-boosting results over dramatic changes.[2][3] Growth momentum includes expansion to multiple states and ambitions for 250-300 U.S. locations, driven by a membership model and specialist focus.[1][4]
Alchemy 43 was founded in 2014 by Nicci Levy, a former corporate cosmetics executive who sought to shift the aesthetics industry from "fixing" flaws to enhancing natural features.[4] After a decade in cosmetics, Levy established Alchemy 43 Management Company in Beverly Hills (later West Hollywood) to make injectables more approachable and integrated into daily life, branding them as "microtreatments" for subtle refreshment.[1][2][4] Early traction came from its specialist model—providers focused solely on aesthetics daily—and backing from prominent VCs like Forerunner Ventures and BAM Ventures, where advisor Shamin Walsh contributed expertise.[2][3] Pivotal moments include opening its first Orange County location in Corona Del Mar in 2023 and steady clinic growth amid rising demand for personalized wellness.[4][5]
Alchemy 43 rides the wave of HealthTech and consumer wellness trends, blending medical aesthetics with personalized, regenerative treatments amid booming demand for non-invasive beauty solutions post-pandemic.[3] Its timing aligns with market forces like rising injectables accessibility—Botox and fillers markets are exploding—and a shift toward subtle, lifestyle-integrated self-care, fueled by social media and aging demographics seeking "filtered" natural looks.[1][4] By operating in the Consumer HealthTech intersection, it influences the ecosystem through scalable clinic models and VC-backed growth, competing with players like Faceland and Neauvia while democratizing specialist care beyond luxury spas.[1][3] This positions it to capitalize on wellness-as-prevention, where aesthetics meets holistic rejuvenation.
Alchemy 43 is primed for aggressive expansion, targeting 250-300 U.S. locations via further funding and operational scaling, as Levy commits to the "battle" for market share in a fragmented injectables space.[1] Trends like AI-driven personalization, peptide integrations, and telehealth wellness will shape its path, potentially amplifying growth through hybrid virtual consultations and franchise models. Its influence may evolve from boutique disruptor to national chain, redefining aesthetics as everyday empowerment—building on its mission to make subtle enhancements ubiquitous and turning "the best work goes unnoticed" into an industry standard.[2][4]
Alchemy 43 has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in December 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2017 | $3.0M Seed | Accel, BoxGroup, FirstMark Capital, Forerunner Ventures, General Catalyst |